Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LUNG
日付受信時刻ニュースソース見出しコード企業名
2024/06/0607 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0607 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0607 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0606 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0606 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0606 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0606 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0606 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/06/0105 : 38Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LUNGPulmonx Corporation
2024/05/2407 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/05/2405 : 24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
2024/05/2306 : 03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
2024/05/1805 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
2024/05/0806 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/05/0706 : 03GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
2024/05/0205 : 05GlobeNewswire Inc.Pulmonx Reports First Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
2024/04/1105 : 05GlobeNewswire Inc.Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:LUNGPulmonx Corporation
2024/04/0305 : 05GlobeNewswire Inc.Pulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerNASDAQ:LUNGPulmonx Corporation
2024/03/1606 : 00GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
2024/03/0810 : 02Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
2024/03/0809 : 57Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
2024/03/0809 : 54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
2024/03/0608 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/03/0608 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/03/0608 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/03/0608 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
2024/03/0106 : 31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LUNGPulmonx Corporation
2024/02/2806 : 07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUNGPulmonx Corporation
2024/02/2710 : 48Business WirePulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-ZulassungsstudieNASDAQ:LUNGPulmonx Corporation
2024/02/2710 : 40Business WirePulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT IINASDAQ:LUNGPulmonx Corporation
 Showing the most relevant articles for your search:NASDAQ:LUNG